Stephen JD - Aadi Bioscience Senior Counsel
| AADIDelisted Stock | USD 2.05 0.05 2.38% |
Executive
Stephen JD is Senior Counsel of Aadi Bioscience
| Age | 49 |
| Phone | 424 744 8055 |
| Web | https://aadibio.com |
Aadi Bioscience Management Efficiency
The company has return on total asset (ROA) of (0.3527) % which means that it has lost $0.3527 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6595) %, meaning that it created substantial loss on money invested by shareholders. Aadi Bioscience's management efficiency ratios could be used to measure how well Aadi Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| MS CPA | Erasca Inc | 58 | |
| MaryAlice JD | Acrivon Therapeutics, Common | 51 | |
| MSc MD | AnaptysBio | N/A | |
| Alexander Santini | Arvinas | 66 | |
| Erik MBA | Ultragenyx | 55 | |
| Magnus DPHIL | Monte Rosa Therapeutics | N/A | |
| David MD | Mineralys Therapeutics, Common | 70 | |
| Minji MBA | Mineralys Therapeutics, Common | N/A | |
| Randy Teel | Arvinas | 45 | |
| Robert McKean | Mineralys Therapeutics, Common | N/A | |
| Edmund Dunn | Monte Rosa Therapeutics | 59 | |
| Katharine CPA | Acrivon Therapeutics, Common | N/A | |
| Arjun Natesan | Ultragenyx | N/A | |
| Vince Hernandez | AN2 Therapeutics | N/A | |
| Sanjeev Khindri | Aerovate Therapeutics | N/A | |
| JD Esq | Erasca Inc | 53 | |
| Garlan Adams | Crinetics Pharmaceuticals | N/A | |
| Michael Varney | Erasca Inc | 67 | |
| Marc CPA | Crinetics Pharmaceuticals | 45 | |
| Tobin Schilke | Crinetics Pharmaceuticals | 50 | |
| Jennifer Huber | AN2 Therapeutics | N/A | |
Management Performance
| Return On Equity | -0.66 | ||||
| Return On Asset | -0.35 |
Aadi Bioscience Leadership Team
Elected by the shareholders, the Aadi Bioscience's board of directors comprises two types of representatives: Aadi Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aadi. The board's role is to monitor Aadi Bioscience's management team and ensure that shareholders' interests are well served. Aadi Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aadi Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Neil Desai, President, Founder | ||
| Raymond Steitz, Senior Officer | ||
| Bryan Ball, Chief Operations | ||
| David Lennon, CEO President | ||
| Marcy Graham, SVP Communications | ||
| Stephen JD, Senior Counsel | ||
| Brendan MBA, Chief Officer | ||
| David Dornan, Chief Officer | ||
| MD FACP, Chief Officer | ||
| Scott CPA, Treasurer, CFO |
Aadi Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aadi Bioscience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.66 | ||||
| Return On Asset | -0.35 | ||||
| Profit Margin | (2.46) % | ||||
| Operating Margin | (1.49) % | ||||
| Current Valuation | 35.53 M | ||||
| Shares Outstanding | 46.29 M | ||||
| Shares Owned By Insiders | 6.09 % | ||||
| Shares Owned By Institutions | 50.02 % | ||||
| Number Of Shares Shorted | 764.36 K | ||||
| Price To Book | 1.41 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Aadi Stock
If you are still planning to invest in Aadi Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aadi Bioscience's history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |